Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Gassama (Birmingham (West Midlands), United Kingdom), L. Sapey (Birmingham (West Midlands), United Kingdom), D. Griffiths (Birmingham (West Midlands), United Kingdom), R. Stockley (Birmingham (West Midlands), United Kingdom), P. Kumar (Birmingham (West Midlands), United Kingdom), A. Turner (Birmingham (West Midlands), United Kingdom). Determinants of arterial stiffness in Alpha-1 Antitrypsin Deficiency. 2196

Member's Comments

No comment yet.

Related content which might interest you: Increased Exacerbations of Chronic Obstructive Pulmonary Disease in Alpha-1 Antitrypsin Carriers Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 ATS / ERS: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Source: Guideline 2003 Year: 2003 Microvascular Endothelial Function in treated Pulmonary Arterial Hypertension Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Role of CHK1 in Pulmonary Arterial Hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Multi-Omics Analysis of the PDGF Response in Pulmonary Vascular Smooth Muscle Cells from Patients with Pulmonary Arterial Hypertension: Implication of the NMDAR Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Iron Deficiency in Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Contribution of BMP9 to Pulmonary Arterial Hypertension Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension Year: 2017 Right Ventricular Failure in an Animal Model of Severe Pulmonary Arterial Hypertension: eNOS Uncoupling and Protein Kinase G Signaling in the Transition from Adaptive to Maladaptive Remodeling Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Noninvasive Arterial Stiffness Measurement in Patients with Sarcoidosis Source: International Congress 2017 – Novel and old entities Year: 2017 LATE-BREAKING ABSTRACT: Evaluation of Angiopoietin-2 and Thrombomodulin as Biomarkers for Pulmonary Hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Role of NMDA receptors in vascular remodelling associated to pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Alpha-1 antitrypsin deficiency severity and the risk of COVID-19 Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Improving the safety of right heart catheterisation in sickle cell disease Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Endothelial microparticles and progenitor cells in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Patients with Alpha-1 antitrypsin Deficiency due to Null mutations have clinical peculiarities and should require personalized pulmonary management Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Lung heparan and chondroitine sulfate imbalance and functional changes in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014